BioSenic (formerly Bone Therapeutics) uploaded a News Release
October 20, 2020
Bone Therapeutics reaches 50% treated patients in ongoing JTA-004 Phase III pivotal knee osteoarthritis study
- Recruitment on track to be completed before year-end